Applied DNA Sciences (APDN)
(Delayed Data from NSDQ)
$0.34 USD
-0.31 (-47.04%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $0.35 +0.01 (1.71%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth B Momentum F VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
APDN 0.34 -0.31(-47.04%)
Will APDN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for APDN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APDN
Zacks Investment Ideas feature highlights: Virax Biolabs Group, GeoVax Labs, Applied DNA Sciences and Emergent BioSolutions
WHO Declares Monkeypox Public Emergency: 5 Mpox Stocks to Watch
APDN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Applied DNA Sciences (APDN) Tops Q3 Earnings Estimates
Axon Enterprise (AXON) Q2 Earnings and Revenues Top Estimates
Ball (BALL) Q2 Earnings Beat Estimates
Other News for APDN
12 Health Care Stocks Moving In Tuesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Intraday Session
Applied DNA Sciences regains Nasdaq compliance
Applied DNA Sciences regains compliance with Nasdaq minimum bid price rule